Hormonal status influences insulin sensitivity, and insulin sensitivity strongly affects how the body responds to GLP-1 medications
Julie Joseph Feb 4, 2025 4 min read Obesity and Type 2 Diabetes has an increasing prevalence worldwide, presenting a major health challenge
Our aim is always to provide safe and reliable options while also making sure you understand that results can vary from person to person
(PubMed) Sola S, Mir MQ, Cheema FA, et al
Clinical Evidence on Weight Regain Rates A major trial tracking semaglutide discontinuation found that 50% of weight loss returns within 12 months after stopping the medication
PlexusDx Personalized Approach to GLP-1 Safety PlexusDx compounds semaglutide and tirzepatide through licensed 503A pharmacies, enabling customized dosing protocols not available through commercial products like Wegovy or Mounjaro